S1PR2 and early-onset autosomal dominant Alzheimer disease: Kim et al. [61] showed that complement component 8 gamma (C8G) reduces neuroinflammation and blood–brain barrier permeability and inhibits glial hyperactivation and cognitive decline in acute and chronic animal models of Alzheimer’s disease by antagonizing S1PR2 activation.